HOME > Archive
Year Class/Forum Presentation Title
Speaker
Download
Lecture Video
KOR ENG
GBC 2021 Keynote & Plenary Keynote Speech A Personalized Approach to Immune Therapies for Cancer: One drug, one patient
Larry Kwak Deputy director of City of Hope's comprehensive cancer center, City of Hope
GBC 2021 Keynote & Plenary Keynote Speech Harnessing Science to Address Unmet Medical and Public Health Needs: Why Regulation Matters
Margaret Hamburg Interim Vice President, Nuclear Threat Initiative
GBC 2021 Keynote & Plenary Keynote Speech A Preclinical Strategy to Improve Clinical Success Rates of Cancer Drug Development
Robert Kerbel Senior scientist, Sunnybrook Health Sciences Centre
GBC 2021 Keynote & Plenary Keynote Speech Regulatory agility and the response to public health threats: a changing environment”
Rogério Gaspar Director, WHO
GBC 2021 Keynote & Plenary Keynote Speech COVID-19: challenge an opportunity
Peter Doherty Peter Doherty Institute at the University of Melbourne, Professor
GBC 2021 Keynote & Plenary Keynote Speech The ubiquitin proteolytic system – from mechanisms to the patient bed and what it takes to make this road
Aaron Ciechanover N/A, Technion-Israel Institute of Technology
GBC 2021 Keynote & Plenary Plenary Session An Overview of the United States Government Program on COVID-19 vaccines
Lawrence Corey Professor, Fred Hutchinson Cancer Research Center
GBC 2021 Keynote & Plenary Plenary Session Challenge and Response to COVID-19
Jong-koo Lee Professor , 서울대학교 병원
GBC 2021 Vaccine Vaccine Forum Overview of mRNA vaccine development and six points to consider when doing research
Jae-Hwan Nam professor, The Catholic University of Korea
GBC 2021 Vaccine Vaccine Forum COVID 19 Vaccine Development
Jerome Hahn Kim Director General, International Vaccine Institute
GBC 2021 Vaccine Vaccine Forum The past and future of regulatory treatment of COVID-19 vaccines - From the initial licensure to future approval of adapted vaccines and indications
Ralf Wagner Head of section for viral vaccines, Paul-Ehrlich-Institut
GBC 2021 Vaccine Vaccine Forum Challenges in improving global access and equity to COVID-19 vaccines
Jinho Shin Medical Officer, WHO
GBC 2021 Vaccine Vaccine Forum COVID 19 vaccine development and the future strategy based on mRNA
Randall Hyer Senior Vice President, Moderna
GBC 2021 Recombinant Protein Products Recombinant Protein Products Forum Current Perspectives on antibody therapeutics for COVID-19
Junho Chung Professor, Seoul National University College of Medicine
GBC 2021 Recombinant Protein Products Recombinant Protein Products Forum Regulatory Approaches to CMC Development During COVID-19: Challenges and Opportunities
Marjorie Shapiro Supervisory Biologist, OBP/OPQ/CDER/FDA
첫페이지 1 2 3 4 5 6 7 8 9 10 다음 10 페이지 마지막페이지